Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising outcomes. However, the cost of this innovative drug and its access have become key issues for patients and healthcare professionals. While tirzepatide has been authorized by regulatory agencies, its costly nature presents a significant obstacle to many. T